178 related articles for article (PubMed ID: 11510196)
1. [A gastroenterologist's choice: proton pump inhibitors of H2 histamine receptor blockers in the treatment of peptic ulcer].
Morozov IA
Klin Med (Mosk); 2001; 79(5):68-71. PubMed ID: 11510196
[No Abstract] [Full Text] [Related]
2. [Gastric acid secretion inhibitors: H2 receptor antagonists (H2RA), proton pump inhibitors (PPI) or acid pump antagonists (APA)].
Mazure PA
Acta Gastroenterol Latinoam; 1996; 26(4):263-5. PubMed ID: 9335935
[No Abstract] [Full Text] [Related]
3. Acid reduction in peptic ulcer disease. Choosing therapy according to drug interactions, individual response, and cost.
Parent K
Postgrad Med; 1994 Nov; 96(6):53-9. PubMed ID: 7971612
[TBL] [Abstract][Full Text] [Related]
4. Proton-pump inhibitors reduce the risk of uncomplicated peptic ulcer in elderly either acute or chronic users of aspirin/non-steroidal anti-inflammatory drugs.
Pilotto A; Franceschi M; Leandro G; Paris F; Cascavilla L; Longo MG; Niro V; Andriulli A; Scarcelli C; Di Mario F
Aliment Pharmacol Ther; 2004 Nov; 20(10):1091-7. PubMed ID: 15569111
[TBL] [Abstract][Full Text] [Related]
5. [Antisecretory therapy as a component of hemostasis in acute gastroduodenal ulcer bleedings].
Gostishchev VK; Evseev MA
Khirurgiia (Mosk); 2005; (8):52-7. PubMed ID: 16091681
[TBL] [Abstract][Full Text] [Related]
6. Management of bleeding peptic ulcer: current status of intravenous proton pump inhibitors.
McCarthy DM
Best Pract Res Clin Gastroenterol; 2004; 18 Suppl():7-12. PubMed ID: 15588788
[TBL] [Abstract][Full Text] [Related]
7. [Therapy of peptic ulcer. H2 receptor blockers].
Domschke W
Verh Dtsch Ges Inn Med; 1988; 94():272-5. PubMed ID: 2905101
[No Abstract] [Full Text] [Related]
8. [Treatment of peptic ulcer with histamine H2-receptor antagonists].
Radbil' OS
Sov Med; 1977 Nov; (11):111-9. PubMed ID: 24276
[No Abstract] [Full Text] [Related]
9. The effect of H2-receptor antagonist and proton pump inhibitor on microbial proliferation in the stomach.
Wang K; Lin HJ; Perng CL; Tseng GY; Yu KW; Chang FY; Lee SD
Hepatogastroenterology; 2004; 51(59):1540-3. PubMed ID: 15362796
[TBL] [Abstract][Full Text] [Related]
10. Drugs for peptic ulcers.
Treat Guidel Med Lett; 2004 Feb; 2(18):9-12. PubMed ID: 15529109
[No Abstract] [Full Text] [Related]
11. Use of anti-secretory medication: a population-based cohort study.
Lassen A; Hallas J; Schaffalitzky De Muckadell OB
Aliment Pharmacol Ther; 2004 Sep; 20(5):577-83. PubMed ID: 15339329
[TBL] [Abstract][Full Text] [Related]
12. [H2 blockers and acute peptic ulcer].
Müller P; Dammann HG; Simon B
Fortschr Med; 1986 Dec; 104(3):903-7. PubMed ID: 2881861
[No Abstract] [Full Text] [Related]
13. Innovations in peptic ulcer disease: histamine 2-receptor antagonists.
Romankiewicz N
J Pract Nurs; 1983; 33(8):8-9. PubMed ID: 6140313
[No Abstract] [Full Text] [Related]
14. [Place and significance of proton pump inhibitors in current treatment of peptic ulcers].
Maev IV
Eksp Klin Gastroenterol; 2003; (3):12-13. PubMed ID: 14989296
[No Abstract] [Full Text] [Related]
15. [The influence of proton-pump inhibitors on the healing process of peptic ulcers--electronic endoscopic study].
Miyahara T; Kawaguchi A; Nogao S; Niwa H
Nihon Rinsho; 1992 Jan; 50(1):98-103. PubMed ID: 1347335
[TBL] [Abstract][Full Text] [Related]
16. [H2 receptor antagonists and proton pump inhibitors: principles and rules of use].
Chassany O; Bergmann JF
Rev Prat; 1998 Apr; 48(8):893-8. PubMed ID: 11767336
[No Abstract] [Full Text] [Related]
17. Risk factors associated with the development of gastroduodenal ulcers due to the use of NSAIDs.
Wolfe MM
Int J Clin Pract Suppl; 2003 Apr; (135):32-7. PubMed ID: 12723745
[TBL] [Abstract][Full Text] [Related]
18. Proton-pump inhibitors are the treatment of choice in acid-related disease.
Brunner G
Eur J Gastroenterol Hepatol; 1996 Oct; 8 Suppl 1():S9-13. PubMed ID: 8930574
[TBL] [Abstract][Full Text] [Related]
19. [Antacids, histamine H2 receptor antagonists].
Raphaël M
Soins; 1988 Apr; (511):I-II. PubMed ID: 2899911
[No Abstract] [Full Text] [Related]
20. Risk of peptic ulcer hospitalizations in users of NSAIDs with gastroprotective cotherapy versus coxibs.
Ray WA; Chung CP; Stein CM; Smalley WE; Hall K; Arbogast PG; Griffin MR
Gastroenterology; 2007 Sep; 133(3):790-8. PubMed ID: 17854591
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
